Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
SCLX
↓ PDF (Pro)Scilex Holding Company Common Stock
HealthcareDrug Manufacturers - GeneralUnited StatesNASDAQ
$9.76
-9.04%today
MKT CAP
$69M
+64.9% · 1Y
Earnings History
-17202.0%
-715.4%
-5093.4%
-149.3%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Full Financials
Trailing P/E-
Forward P/E11.0x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-54.6%
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership17.6%
Institutional Ownership13.4%
Short % of Float2.87%
Days to Cover4.3d
1 Week+58.1%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| SCILEX HOLDING CO | Beneficial Owner of more than 10% of a Class of Security | Sale | 20,657,300 | $12.30 | $270.81M | 2025-12-30 |
| SHAH JAISIM | Chief Executive Officer | Buy | 30,000 | $0.46 | $0.01M | 2024-12-18 |
| JI HENRY H | Officer and Director | Buy | 8,888 | $0.94 | $0.01M | 2024-10-31 |
| SHAH JAISIM | Chief Executive Officer | Buy | 32,000 | $0.99 | $0.03M | 2024-10-29 |
| FOLLOWWILL DORMAN | Director | Buy | 1,000 | $0.99 | $0.00M | 2024-10-18 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Armistice Capital, LLC | institution | 5.61% | $0.00B | +622.23% | 2025-12-31 |
| Vanguard Group Inc | institution | 3.47% | $0.00B | +4.46% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.00% | $0.00B | +6.84% | 2025-12-31 |
| Blackrock Inc. | institution | 1.16% | $0.00B | -0.05% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.90% | $0.00B | +0.00% | 2025-12-31 |
| Renaissance Technologies, LLC | institution | 0.45% | $0.00B | +100.71% | 2025-12-31 |
| State Street Corporation | institution | 0.40% | $0.00B | +2.75% | 2025-12-31 |
| 683 Capital Management LLC | institution | 0.32% | $0.00B | +100.00% | 2025-12-31 |
| Xtx Topco Ltd | institution | 0.24% | $0.00B | +100.00% | 2025-12-31 |
| Citigroup Inc. | institution | 0.23% | $0.00B | +100.00% | 2025-12-31 |
| Ashton Thomas Private Wealth, LLC | institution | 0.21% | $0.00B | +0.00% | 2025-12-31 |
| iShares Trust-iShares Micro-Cap ETF | fund | 0.21% | $0.00B | +9.72% | 2026-03-31 |
| Northern Trust Corporation | institution | 0.18% | $0.00B | -0.82% | 2025-12-31 |
| iShares Trust-iShares Core S&P Total U.S. Stock Market ETF | fund | 0.17% | $0.00B | +0.00% | 2026-03-31 |
| T. ROWE PRICE INDEX TRT, INC.-T. Rowe Price Extended Eqy. Market Index | fund | 0.08% | $0.00B | -4.19% | 2025-12-31 |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | fund | 0.04% | $0.00B | +0.00% | 2025-12-31 |
| -Price (T.Rowe) U.S. Equities Trust | fund | 0.04% | $0.00B | +1346.15% | 2025-12-31 |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | fund | 0.03% | $0.00B | +0.00% | 2025-12-31 |
| Brighthouse Funds Trust II-MetLife Russell 2000 Index Portfolio | fund | 0.01% | $0.00B | +0.00% | 2025-12-31 |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | fund | 0.01% | $0.00B | +0.00% | 2025-12-31 |
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| MIRA | $42M | 5 | - | - | - | - | - | - | 0.00% |
| AMRN | $312M | 80 | - | 14.7 | - | - | - | - | 0.00% |
| OGN | $3.5B | 91 | 14.3 | 3.6 | - | - | - | - | 0.60% |
| GRFS | $5.7B | 100 | 12.0 | 5.7 | 10.1 | 6.1% | 38% | 123.22 | 0.00% |
| BIIB | $28.1B | 68 | 20.6 | 11.6 | 8.7 | 7.7% | 79% | 35.18 | 0.00% |
| GSK | $101.8B | 65 | 13.1 | 9.7 | 19.1 | 40.9% | 73% | 109.70 | 344.00% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for SCLX.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.